Plans for a new 28-bed care centre are set for approval in a south Suffolk village, despite receiving several objections. Babergh District Council's planning committee is set to meet on Wednesday ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback